Rule 1: If the molecular structure contains a functional group such as "-CCl" or "-SCN", it may have adverse effects on the body. This rule applies specifically to molecules listed between rows 6 to 78.
Rule 2: If a molecule contains a sulfonamide group (-SO2NH-), it could potentially result in adverse effects related to congenital, familial, and genetic disorders. 
Rule 3: A molecule that contains a nitro group (-NO2) attached to an aromatic ring may lead to adverse effects related to congenital, familial, and genetic disorders. 
Rule 4: If a molecule consists of a halogen atom (such as chlorine or fluorine) attached to an aromatic ring, it could potentially lead to adverse effects related to congenital, familial, and genetic disorders.
Rule 5:  If the molecule contains a bromine atom, it might cause adverse effects related to congenital, familial, and genetic disorders.
Rule 6: If a molecule contains a fluorine atom, it might also cause adverse effects related to congenital, familial, and genetic disorders.
Rule 7:  A molecule that holds a cyano group (-CN) may have the potential to cause adverse effects related to neurological disorders like Alzheimer's disease or Parkinson's disease.
Rule 8: If there's a functional group like carbonyl or carboxylic acid present in the structure, it may lead to adverse effects due to increased reactivity.
Rule 9: Molecules with high molecular weight may result in adverse effects due to increased hydrophobicity leading to potential toxic effects.
Rule 10: Compounds with aromatic rings could exhibit toxic effects on living organisms, leading to potential adverse effects.
Rule 11: If the molecule has a chlorine atom bonded to a carbon atom in a five-membered ring, it might cause adverse effects related to congenital, familial, and genetic disorders.
Rule 12: Molecules containing a carbonyl group (C=O) attached to a cyclopropane ring can cause potential adverse effects.
Rule 13: If a molecule consists of a nitrogen atom bonded to two carbon atoms and one oxygen atom, it may lead to adverse effects related to congenital, familial, and genetic disorders.
Rule 14: Compounds containing sulfonamide, nitro, or halogen groups might increase the chances of causing adverse effects.
Rule 15: Compounds with a high degree of lipophilicity might increase the chances of crossing cell membranes leading to higher toxicity and adverse effects.
Rule 16: The length and complexity of a compound's structure could affect its ability to cross cell membranes and can increase their potential adverse effects.
Rule 17: If a molecule contains a benzene ring attached to a cyano group (-CN) through a single bond, it might cause adverse effects related to congenital, familial, and genetic disorders.
Rule 18: If a molecule has a phosphorus atom bonded to four other atoms including two oxygen atoms, it may cause adverse effects related to congenital, familial, and genetic disorders.
Rule 19: If the molecule contains a sulfonamide group (-SO2NH-) attached to an aromatic ring, it could possibly cause adverse effects related to congenital, familial, and genetic disorders.
Rule 20: A molecule with a nitro group (-NO2) attached to an aromatic ring could induce adverse effects related to cancer or other diseases.
Rule 21: If a molecule has a functional group called "carbonyl" or "nitrile", it could induce adverse effects related to congenital, familial, and genetic disorders.
Rule 22: If there is any occurrence of the SMILES string "CC#N" or "Cc1ccccc1" in the molecular structure, then it may cause adverse effects related to congenital, familial, and genetic disorders.
Rule 23:  If a molecule contains a cyano group (-CN) or a fluoro group (-F), it may have the potential to cause adverse effects in patients.
Rule 24: If a molecule consists of a sulfonyl group (-SO2-), a nitro group (-NO2) or both, it might possess potential adverse effects in humans.
Rule 25: If a molecule contains both a chlorine atom and a carbonyl group (-C=O), it might have potential adverse effects in humans. 
Rule 26: If a molecule contains a sulfhydryl group (-SH), a nitro group (-NO2), a halogen atom such as chlorine or fluorine attached to a carbon atom it may potentially cause adverse effects in patients.
Rule 27: If the molecule contains a sulfonyl group (-SO2-), a nitro group (-NO2), or both, it may result in potential adverse effects in humans.
Rule 28: If a molecule contains a functional group called "carbonyl" or "nitrile", it may have the potential to cause adverse effects related to congenital, familial, and genetic disorders. 
Rule 29: If a compound contains a sulfonamide group (-SO2NH-), a quinazoline ring system (-C8H6N2-) or a coumarin ring system (-C9H6O2-), it may result in adverse effects related to conditions such as congenital, familial, and genetic disorders, or even cancer.
Rule 30: If a molecule contains a sulphonamide group (-SO2NH-) or a nitro group (-NO2) attached to an aromatic ring, it may cause adverse effects in humans.
Rule 1: A molecule may cause adverse effects if it contains a benzene ring, an aromatic system, a metal ion, or fluorine atoms.
Rule 2: A molecule may cause adverse effects if it contains a sulfonamide group (-SO2NH-), a nitro group (-NO2), a carboxylate ion (-COO-), or a carbonate ion (-CO3^2-).
Rule 3: A molecule may cause adverse effects if its molecular formula contains sodium ions or indium ions, or if it includes a functional group such as sulfonamide, nitro, or halogen groups, or a benzene ring or polycyclic aromatic hydrocarbons.
Rule 4: A molecule may bear side-effects related to congenital, familial, and genetic disorders if it contains a chlorine atom bonded to a carbon atom, a carbonyl group (-C=O) adjacent to a double bond. It may not cause side-effects related to these disorders if it contains a cyano group (-CN) or a thiocarbonyl group (-CS-).
Rule 5: A molecule may cause adverse effects in individuals with congenital, familial, and genetic disorders if it contains a functional group such as C=O or CC, and may not cause adverse effects if it contains a functional group such as NC or NCC, or a metal ion such as Cl or Na.
Rule 6: A molecule may cause adverse effects in patients who have congenital, familial, and genetic disorders if it contains a cyano group (-CN) or a fluoro group (-F).
